The Definitive Peptide Research Reference Guide — Compound Review

Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Peptide Reconstitution Guide Peptide Injection Sites Guide Peptide Storage Guide Semaglutide Dosage BPC-157 Dosage Research Guides Joint Pain Weight Loss Longevity Vendor Scoreboard All Vendor Comparisons Peptide Price Comparison Vendor Closures & Status How to Read a Peptide COA How to Vet a Peptide Vendor Why Purgo Labs Purgo Labs Review Purgo Labs Discount Code Where to Buy by Compound Legal Status Shop Purgo Labs

CJC/Ipamorelin Blend Dosage Guide

Pre-mixed CJC-1295/Ipamorelin blend: convenience formulation combining both peptides in a single vial for simultaneous administration.

Standard Blend Dosage

Typical blend concentration: 2 mg CJC-1295 + 2 mg Ipamorelin per vial. Research dose: 0.1 mL (100 mcg each) to 0.2 mL (200 mcg each) per injection, 2–3x daily subcutaneously.

Blend vs Separate Administration

Pre-mixed blends offer convenience but limit dose flexibility. Separate administration allows independent dose adjustment of each compound — useful when optimizing the CJC:Ipamorelin ratio for specific research endpoints.

Research Endpoints

Combined GH/IGF-1 elevation, body composition changes (lean mass gain, fat reduction), sleep quality improvement, and recovery acceleration are the primary endpoints in CJC/Ipamorelin research protocols.